NEW YORK (TheStreet) -- Endo International (ENDP) shares closed trading down 0.41% to $86.68 on Monday following the release of the company's first quarter earnings results before the opening bell today.
The Dublin, Ireland-based specialty healthcare company reported first quarter earnings of $124.5 million, after reporting a net loss during the same period last year, or an EPS of $1.17 per share. Revenue for the period increased 51.6% over the same period last year to $714.1 million.
Analysts on average were expecting the company to report earnings of $1.06 per share on revenue of $711.78 million.
The company also raised its full year guidance to between $4.40 and $4.60 per share from its previous view between $4.35 and $4.55 per share on revenue between $2.9 billion and $3 billion. Analysts on average are expecting the company to report earnings of $4.47 per share on revenue of $2.99 billion.
TheStreet Ratings team rates ENDO INTERNATIONAL PLC as a Hold with a ratings score of C. TheStreet Ratings Team has this to say about their recommendation:
"We rate ENDO INTERNATIONAL PLC (ENDP) a HOLD. The primary factors that have impacted our rating are mixed - some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and increase in net income. However, as a counter to these strengths, we find that the company has favored debt over equity in the management of its balance sheet."